Progyny trust proposes $1.8M sale of common shares
The shares are attributed to restricted stock units, performance stock units and the employee stock purchase plan during January 1, 2022 through March 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Progyny, Inc. (PGNY) is identified as the issuer for 50,139 common shares listed for proposed sale for the account of Anevski 2026 South Dakota NGCG Trust. The approximate sale date is November 10, 2026, and the aggregate market value is $1,802,497.05. Acquisition information identifies the issuer as the source and lists restricted stock units, performance stock units and the employee stock purchase plan, with the period stated as January 1, 2022 through March 3, 2026. The Rule 10b5-1 plan adoption date is July 2, 2026.
Key Figures
Key Terms
Restricted Stock Units technical
Performance Stock Units technical
Employee Stock Purchase Plan technical
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.